These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32008423)

  • 21. Safe harbors in Europe: an update on the research and Bolar exemptions to patent infringement.
    Kupecz A; Roox K; Dekoninck C; Schertenleib D; Stief M; Sanna F; Orsingher M; Miralles S; Molina E; Crosse T; Gilbert M; James W
    Nat Biotechnol; 2015 Jul; 33(7):710-5. PubMed ID: 26154008
    [No Abstract]   [Full Text] [Related]  

  • 22. Science and the law. Working through the patent problem.
    Walsh JP; Cohen WM; Arora A
    Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
    [No Abstract]   [Full Text] [Related]  

  • 23. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 24. Trends in the human embryonic stem cell patent field.
    Karlsson U; Hyllner J; Runeberg K
    Recent Pat Nanotechnol; 2007; 1(3):233-7. PubMed ID: 19076035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 26. Framing the patent troll debate.
    Risch M
    Expert Opin Ther Pat; 2014 Feb; 24(2):127-30. PubMed ID: 24354803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Companies balk at California's patent rules for stem cell research.
    Keim B
    Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene patenting and medical research: a view from a pharmaceutical company.
    Stott M; Valentine J
    Nat Rev Drug Discov; 2004 Apr; 3(4):364-8. PubMed ID: 15060532
    [No Abstract]   [Full Text] [Related]  

  • 29. Patent dispute threatens US Alzheimer's research.
    Hayden EC
    Nature; 2011 Apr; 472(7341):20. PubMed ID: 21475170
    [No Abstract]   [Full Text] [Related]  

  • 30. [Not Available].
    Dötsch J; Endres S
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S2. PubMed ID: 30453359
    [No Abstract]   [Full Text] [Related]  

  • 31. [Patents in biomedical research].
    Ishino M
    Tanpakushitsu Kakusan Koso; 2003 Sep; 48(12):1753-5. PubMed ID: 12971278
    [No Abstract]   [Full Text] [Related]  

  • 32. Intellectual property. Fixing the legal framework for pharmaceutical research.
    Knowles SM
    Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445
    [No Abstract]   [Full Text] [Related]  

  • 33. Britain reevaluates taxes on patent income.
    Dolgin E
    Nat Med; 2010 Jan; 16(1):13. PubMed ID: 20057407
    [No Abstract]   [Full Text] [Related]  

  • 34. Reforming the Orphan Drug Act for the 21st Century.
    Sarpatwari A; Kesselheim AS
    N Engl J Med; 2019 Jul; 381(2):106-108. PubMed ID: 31291512
    [No Abstract]   [Full Text] [Related]  

  • 35. Anchoring gene patent eligibility to its constitutional mooring.
    Chahine KG
    Nat Biotechnol; 2010 Dec; 28(12):1251-5. PubMed ID: 21139606
    [No Abstract]   [Full Text] [Related]  

  • 36. Biotechnology--a challenge to the patent system.
    Farnley S; Morey-Nase P; Sternfeld D
    Curr Opin Biotechnol; 2004 Jun; 15(3):254-7. PubMed ID: 15193336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV
    Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract]   [Full Text] [Related]  

  • 38. KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.
    Bouchard RA
    Health Law J; 2007; 15():247-94. PubMed ID: 19702185
    [No Abstract]   [Full Text] [Related]  

  • 39. The impact of effective patents on future innovations in nanomedicine.
    Bosetti R; Vereeck L
    Pharm Pat Anal; 2012 Mar; 1(1):37-43. PubMed ID: 24236712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protect pharmaceutical innovation.
    Musselwhite LW; Andrews J
    Science; 2010 Jun; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.